BCAX
BCAX
US0554771032
Bicara Therapeutics Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
155.604.000 82.389.000
88.9%
Operating Income -155.604.000 -82.389.000
88.9%
Pretax Income -137.733.000 -67.808.000
103.1%
Net Income Common Stockholders -137.950.000 -67.995.000
102.9%
-- --
--
-- --
--
ende